3-Chloro-PCP (3'-Cl-PCP) is a recreational designer drug from the arylcyclohexylamine family, with dissociative effects. It has comparable potency to phencyclidine but with a slightly different effects profile, being somewhat more potent as an NMDA antagonist but around the same potency as a dopamine reuptake inhibitor.[1] It was first identified in Slovenia in December 2020,[2] and was made illegal in Hungary in April 2021.[3]
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C17H24ClN |
Molar mass | 277.84 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ Catalani V, Arillotta D, Corkery JM, Guirguis A, Vento A, Schifano F (2020). "Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach". Frontiers in Psychiatry. 11: 632405. doi:10.3389/fpsyt.2020.632405. PMC 7900492. PMID 33633599.
- ^ "Analytical Report. 3Cl-PCP (C17H24ClN). 1-[1-(3-chlorophenyl)cyclohexyl]piperidine" (PDF). National Forensic Laboratory. Slovenia.
- ^ "Amendment of Minister for Human Capacities Decree No 55/2014 on substances or groups of compounds classified as new psychoactive substances, 2021/225/HU". Minister for Human Capacities. 30 December 2014.